Amyotrophic lateral sclerosis (ALS) is a fatal heterogeneous neurodegenerative disease that lacks effective treatment option. Researchers at Genervon Biopharmaceuticals hypothesized that the traditional single-target approach to treat neurodegenerative...
Read More »